Comment on "SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect"

Rose Peronard, Stephan Mayntz

5 Citations (Scopus)

Original language	English
Journal	American Journal of Cardiovascular Drugs
Volume	25
Issue number	1
Pages (from-to)	129-130
Number of pages	2
ISSN	1175-3277
DOIs	https://doi.org/10.1007/s40256-024-00706-9
Publication status	Published - Jan 2025

Access to Document

@article{37f850aba1e344d5b4fc02ac23d81af3,

title = "Comment on {"}SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect{"}",

author = "Rose Peronard and Stephan Mayntz",

year = "2025",

month = jan,

doi = "10.1007/s40256-024-00706-9",

language = "English",

volume = "25",

pages = "129--130",

journal = "American Journal of Cardiovascular Drugs",

issn = "1175-3277",

publisher = "Adis",

number = "1",

}

TY - JOUR

T1 - Comment on "SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect"

AU - Peronard, Rose

AU - Mayntz, Stephan

PY - 2025/1

Y1 - 2025/1

UR - https://www.scopus.com/pages/publications/85212227239

U2 - 10.1007/s40256-024-00706-9

DO - 10.1007/s40256-024-00706-9

M3 - Comment/debate

C2 - 39680272

SN - 1175-3277

VL - 25

SP - 129

EP - 130

JO - American Journal of Cardiovascular Drugs

JF - American Journal of Cardiovascular Drugs

IS - 1

ER -